CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Sacral Nerve Stimulation for Urinary and/or Bowel Incontinence: Clinical and Cost-Effectiveness and Guidelines

Last updated: December 22, 2016
Project Number: RB1047-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of InterStim neuromodulation therapy for patients with urinary and/or bowel incontinence?
  2. What is the cost-effectiveness of InterStim neuromodulation therapy for patients with urinary and/or bowel incontinence?
  3. What are the evidence-based guidelines associated with use of sacral nerve stimulation for patients with urinary and/or bowel incontinence?

Key Message

Four evidence-based guidelines were identified regarding the use of sacral nerve stimulation for adult patients with urinary incontinence.